PUBLISHER: Grand View Research | PRODUCT CODE: 2151825
PUBLISHER: Grand View Research | PRODUCT CODE: 2151825
The global lacrimal cannula market size was valued at USD 21.0 million in 2025 and is projected to grow from USD 22.4 million in 2026 to USD 36.7 million by 2033, at a CAGR of 7.3% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 34.5% in 2025. The rising burden of lacrimal drainage disorders, including nasolacrimal duct obstruction, canalicular stenosis, chronic dacryocystitis, and congenital tear duct obstruction, is driving demand for lacrimal cannulas.
These disorders can impair normal tear drainage and cause symptoms such as excessive tearing, recurrent eye infections, irritation, and inflammation. Diagnosis requires assessment of the lacrimal drainage pathway to identify the location and extent of obstruction. Lacrimal irrigation and probing are commonly used for this purpose, with cannulas enabling controlled delivery of saline or other fluids through the canalicular system. In some cases, these procedures are also performed as part of therapeutic management to restore or evaluate drainage. Ophthalmologists manage a broader range of acquired and congenital lacrimal conditions, and the need for specialized instruments for examination and treatment increases. This supports the consumption of lacrimal cannulas across hospitals and ophthalmic clinics.
For instance, data published by the American Academy of Ophthalmology in 2025 indicate that epiphora is a very common complaint and that nasolacrimal duct obstruction (NLDO) is the most common cause of persistent epiphora. The incidence of NLDO is reported as 20.24 per 100,000. In this incidence study, NDLO accounted for 31.8% of all chronic epiphora and 67.6% of all tear drainage pathway obstructions.
The expansion of specialty eye-care infrastructure is supporting the market by increasing access to hospitals, dedicated ophthalmology centers, ambulatory surgical facilities, and subspecialty services for diagnosing and treating lacrimal drainage disorders. As more healthcare facilities develop capabilities in oculoplastic and lacrimal care, the number of settings performing procedures such as lacrimal irrigation, probing, nasolacrimal duct assessment, and canalicular interventions continues to expand. Lacrimal irrigation requires specialized cannulas to deliver saline in a controlled manner through the canalicular system, making these instruments an important component of lacrimal diagnostic practice. The development of specialized eye-care infrastructure also improves access to trained ophthalmologists and dedicated surgical teams, supporting the use of precision instruments. Expansion across emerging healthcare markets creates additional opportunities for manufacturers to supply reusable and disposable cannulas in different gauges, lengths, and configurations. As specialty facilities expand their diagnostic and surgical capabilities, the addressable base of healthcare providers using lacrimal cannulas also broadens, supporting market demand.
Global Lacrimal Cannula Market Report Segmentation
This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends across each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global lacrimal cannula market report based on product, design, gauge size, application, end-use, and region: